Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer

Fig. 5

Global Prognostic Values of IAPs for patient survival. IAPs differed in the prognostic values among different cancers. Higher IAPs expression were associated with shorter survival most of the time, but there were also cases where higher expression was significantly associated with longer survival. Among all the IAPs, BIRC5 emerged as the most potent marker for survival with broad spectrum of prognostic utility across multiple cancers. (a). Kaplan-Meier curves showing high BIRC5 expression was associated with poor overall survival in LGG (b), KIRC (c) and ACC (d)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us